Recently, Li et al. identified 11C-PE2, a highly specific DAT radioligand suitable for PET imaging, as a potential alternative surrogate biomarker for studies of PD progression for its ability to track changes in motor performance over time in 33 PD subjects [154]. This evidence concerns the gene SLC6A3 and Parkinson disease.